On this page
The editorial assessment
A placeholder is not a usable quote. What is the confirmed total before payment, and which entity and pharmacy are responsible for the approved order?
- Published payment basis
- Page labels prices as placeholders pending confirmation
- Preparation record
- BPC-157 prescription request; final product pharmacy-prepared
- Care process
- US-licensed-provider intake review before fulfillment
- Access setting
- US telehealth and shipping description
What is documented
- US-licensed-provider intake review before fulfillment
- A placeholder is not a usable quote
What needs an answer
- The page displays plan figures while explicitly calling pricing a placeholder, so this review does not rank the service on those numbers.
- What is the confirmed total before payment, and which entity and pharmacy are responsible for the approved order?
The price disclaimer overrides the apparent precision
An exact-looking number has little comparative value when its own page identifies it as a placeholder. Van's intake and pharmacy-fulfillment description establishes a proposed service pathway, but not the eventual bill or prescription. The cost planner should carry an unconfirmed amount rather than manufacture a ranking from provisional figures.
The unresolved term
What is the confirmed total before payment, and which entity and pharmacy are responsible for the approved order?
A contrasting service record
The ACT 2 Health service review documents another purchasing structure: the provider distinguishes a package price from a monthly amount and explicitly leaves ordered laboratory work outside that price. That distinction changes which components belong in a like-for-like comparison.
On the record
The documents supporting this report.
- Van Peptides official BPC-157 service or pricing recordCompany website